The effect of nalbuphine on prevention of emergence delirium in children: a systematic review with meta-analysis
Ka Ting Ng, Wei En Lim, Wan Yi Teoh, Mohd Fitry Bin Zainal Abidin
Abstract
Background
Emergence delirium remains a major postoperative concern for children undergoing surgery. Nalbuphine is a synthetic mixed agonist-antagonist opioid, which is believed to reduce the incidence of emergence delirium in children. The primary objective was to examine the effect of nalbuphine on emergence delirium in children undergoing surgery.
Methods
Databases of MEDLINE, EMBASE, and CENTRAL were searched from their starting dates until April 2023. Randomized Clinical Trials (RCT) and observational studies comparing nalbuphine and control in children undergoing surgery were included.
Results
Eight studies (n = 1466 patients) were eligible for inclusion of data analysis. Compared to the control, our pooled data showed that the nalbuphine group was associated with lower incidence of emergence delirium (RR = 0.38, 95% CI [0.30, 0.47], p < 0.001) and reduced postoperative pain scores (MD = -0.98, 95% CI [-1.92, -0.04], p = 0.04).
Conclusions
This review showed the administration of nalbuphine is associated with significant decrease in the incidence of emergence delirium and postoperative pain scores among children undergoing surgery. However, due to limited sample size, high degree of heterogeneity and low level of evidence, future adequately powered trials are warranted to explore the efficacy of nalbuphine on emergence delirium among the pediatric population.
Keywords
Referências
1. Dahmani S, Delivet H, Hilly J. Emergence delirium in children: An update. Curr Opin Anaesthesiol. 2014;27:309−15.
2. Vlajkovic GP, Sindjelic RP. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007;104:84−91.
3. Lerman J. Emergence delirium and agitation in children - UpToDate [Internet]. UpToDate. 2023 [cited 2023 Apr 4]. Available from: https://www.uptodate.com/
4. Urits I, Peck J, Giacomazzi S, et al. Emergence Delirium in Perioperative Pediatric Care: A Review of Current Evidence and New Directions. Adv Ther. 2020;37:1897−909.
5. Lepouse C, Lautner CA, Liu L, Gomis P, Leon A. Emergence delir- ium in adults in the post-anaesthesia care unit. BJA. 2006; 96:747−53.
6. Lee SJ, Sung TY. Emergence agitation: Current knowledge and unresolved questions. Korean J Anesthesiol. 2020;73:471−85.
7. Kim HS, Byon HJ, Kim JE, Park YH, Lee JH, Kim JT. Appropriate dose of dexmedetomidine for the prevention of emergence agitation after desflurane anesthesia for tonsillectomy or adenoidectomy in children: Up and down sequential allocation. BMC Anesthesiology. 2015;15:1−6.
8. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole. J Clin Anesth. 1993;5:194−203.
9. Cohen IT, Drewsen S, Hannallah RS. Propofol or midazolam do not reduce the incidence of emergence agitation associated with desflurane anaesthesia in children undergoing adenotonsillectomy. Paediatr Anaesth. 2002;12:604−9.
10. Zeng Z, Lu J, Shu C, Chen Y, Guo T, Wu QP, et al. A Comparision of Nalbuphine with Morphine for Analgesic Effects and Safety: Meta-Analysis of Randomized Controlled Trials. Sci Rep. 2015;5:10927.
11. Larsen D, Maani CV. Nalbuphine. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [cited 2023 Apr 09]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534283/.
12. Kubica-Cielinska A, Zieli nska M. The use of nalbuphine in paedi- atric anaesthesia. Anaesthesiol Intensive Ther. 2015;47:252−6.
13. Chen ZM, Gao BH, Wang LS. Effect of two different doses of nalbuphine for postoperative analgesia in children with cleft palate: a randomized controlled trial. BMC Anesthesiol. 2024;24:1−6.
14. He J, Zhang L, Tao T, et al. Nalbuphine reduces the incidence of emergence agitation in children undergoing Adenotonsillectomy: A prospective, randomized, double-blind, multicenter study. J Clin Anesth. 2023: 85.
15. Kim HJ, Kim HS, Kim SD, et al. Effects of propofol and nalbuphine on emergence agitation after sevoflurane anesthesia in children for strabismus surgery. Korean J Anesthesiol. 2008; 55:575−8.
16. Mohammed KSA, Ali KEDH, Ahmed HEA, Ibrahem HA. Comparative study between midazolam versus nalbuphine on prevention of emergence agitation after sevoflurane anesthesia in pediatric patients undergoing tonsillectomy with or without adenoidectomy. Tanta Med Jour. 2017;45:73.
17. Noor El-Din T, Sharaf M, Alkumity A, Mahmoud E, Eman AS. Midazolam Versus Nalbuphine On Prevention Of Emergence Agitation In Pediatric Patients On Sevoflurane Anesthesia. Al-Azhar Med J. 2018;47:537−85.
18. Vavrina M, Zurek J, Fedora M, Dominik P, Forbelska M, Biener- tova-Vasku J. Reduction of paediatric emergence agitation after adenotonsillectomy with nalbuphine. Curr Pediatr Res. 2017;21:490−6.
19. Zhao N, Wu Y, Yu C. Effect of intravenous nalbuphine on emergence agitation in children undergoing dental surgery under sevoflurane anesthesia. Int J Clin Exp Med. 2018;11:10215−22.
20. Chang H, Hong H, Lee J, et al. Effect of Nalbuphine on Emergence Agitation and Recovery after Desflurane Anesthesia in Children for Strabismus Surgery. Korean J Anesthesiol. 2008;54.
21. Gao XN, Nie XY, Gao JL, et al. Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver Dysfunction. Drug Des Devel Ther. 2022;16:2383−93.
22. Ji K, Gong X, Luan T, Gao X, Zang B. Pain management of nalbuphine and sufentanil in patients admitted intensive care unit of different ages. BMC Emerg Med. 2022: 22.
23. Higgins JPT, Thomas J, Chandler J, eds. Cochrane handbook for systematic reviews of interventions version 6.4 (updated August 2023), Cochrane; 2023. Available from www.training.cochrane. org/handbook.
24. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372372:n71.
25. Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
26. Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Insititute. 2011.
27. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schune- € mann HJ. Rating Quality of Evidence and Strength of Recommendations: What is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336:995.
28. Review Manager (RevMan) [Computer program]. Version 5.4. The Cochrane Collaboration; 2020.
29. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
30. Elagamy AE, Mahran MG, Mahmoud AZ. Dexmedetomidine versus nalbuphine in prevention of emergence agitation following adenotonsillectomy in pediatrics. Egypt J Anaesth. 2020;36: 24−9.
31. De Souza EB, Schmidt WK, Kuhar MJ. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J Pharmacol Exp Ther. 1988;244:391−402.
32. Gunion MW, Marchionne AM, Anderson CTM. Use of the mixed agonist−antagonist nalbuphine in opioid based analgesia. Acute Pain. 2004;6:29−39.
33. Moore AD, Anghelescu DL. Emergence Delirium in Pediatric Anesthesia. Pediatr Drugs. 2017;19:11−20.
34. Voepel-Lewis T, Malviya S, Tait A. Prospective Cohort Study of Emergence Agitation in the Pediatric Post Anesthesia Care Unit. Anesth Analg. 2003;96:1625−30.
35. Khan J, Liu M. Desflurane [Internet]. StatPearls: StatPearls Publishing; 2022. p. 1−4https://www.ncbi.nlm.nih.gov/books/ NBK537106/.
36. Locatelli BG, Ingelmo PM, Emre S, et al. Emergence delirium in children: a comparison of sevoflurane and desflurane anesthesia using the Paediatric Anesthesia Emergence Delirium scale. Paediatr Anaesth. 2013;23:301−8.
37. Bajwa SA, Costi D, Cyna AM. A comparison of emergence delirium scales following general anesthesia in children. Paediatr Anaesth. 2010;20:704−11.
38. Xi MY, Li SS, Zhang C, Zhang L, Wang T, Yu C. Nalbuphine for Analgesia After Orthognathic Surgery and Its Effect on Postoperative Inflammatory and Oxidative Stress: A Randomized DoubleBlind Controlled Trial. J Oral Maxillofac Surg. 2020;78:528−37.
39. Ruan D, Wang Y, Li S, Zhang C, Zheng W, Yu C. Nalbuphine alleviates inflammation by down-regulating NF-kB in an acute inflammatory visceral pain rat model. BMC Pharmacol Toxicol. 2022; 23:1−10.
40. Rao ZA, Choudhri A, Naqvi S. Ehsan-ul-Haq. Walking epidural with low dose bupivacaine plus tramadol on normal labour in primipara. J Coll Physicians Surg Pak. 2010;20:295−8.
41. Cayrol T, van den Broeke EN. Central sensitisation: causes, therapies, and terminology. Lancet Rheumatol. 2021;3:e548.
42. Kruszynski Z, Jaworska-Grajek M, Wiewi orowski K, Warzybok K. Comparative studies of nalbuphine and morphine in the therapy of postoperative pain in gynecology. Gineko Pol. 1989;60:216−22.
43. Blount RL, Loiselle KA. Behavioural assessment of pediatric pain. Pain Res Manag. 2009;14:47−52.
44. McCormack HM, Horne DJ de L, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18:1007−19.
45. Bogra J, Arora N, Srivastava P. Synergistic effect of intrathecal fentanyl and bupivacaine in spinal anesthesia for cesarean section. BMC Anesthesiol. 2005;5:5.
46. Benzon HA, Shah RD, Benzon HT. Perioperative Nonopioid Infusions for Postoperative Pain Management. Essentials of Pain Medicine. Fourth. Elsevier. 2018. 111-116.e2.
47. Zeng Z, Lu J, Shu C, Chen Y, Guo T, Wu QP, et al. A comparison of nalbuphine with morphine for analgesic effects and safety: meta-analysis of randomized controlled trials. Sci Rep. 2015; 5:10927.
48. Boland J, Boland E, Brooks D. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone. Clin Med (Lond). 2013; 13:149−51.
49. Shebl E, Mirabile VS, Sankari A, Burns B. Respiratory Failure [Internet]. Treasure Island (FL). StatPearls Publishing. StatPearls Publishing; 2023. [cited 2023 Apr 09]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526127/.
Submetido em:
27/12/2023
Aceito em:
11/07/2024
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email